Literature DB >> 8063228

Extent of the acute phase response in fulminant hepatic failure.

S Izumi1, R D Hughes, P G Langley, J R Pernambuco, R Williams.   

Abstract

The extent of the acute phase response and the relation between acute phase proteins and cytokines in plasma was investigated in 50 patients with fulminant hepatic failure. On admission, C reactive protein was significantly higher in fulminant hepatic failure (median: 12.4 micrograms/ml, range:0.2-112 micrograms/ml) than in 20 controls (median: 0.8 microgram/ml, range: 0.3-2.9 micrograms/ml, p < 0.001). Serial measurements showed that plasma C reactive protein increased daily after admission until day 5, the end of the study period. alpha 1-Antitrypsin (AAT) (median: 69.1%, range: 27.5-124%) and fibrinogen (median: 1.10 g/l, range: 0-2.82 g/l) were significantly lower in fulminant hepatic failure on admission than in controls (AAT: median: 126%, range: 75.4-149%; fibrinogen: median 2.48 g/l, range: 1.82-3.39 g/l, p < 0.001) and did not change subsequently. Both AAT and fibrinogen were maintained at significantly higher concentrations in survivors than in those who did not. Bacterial infection occurred in 23 patients during the course of fulminant hepatic failure, but did not influence the concentrations of these three proteins. Interleukin 6 was significantly higher in fulminant hepatic failure (median: 21.2 pg/ml, range: 0-871 pg/ml) than in controls (median: 2.4 pg/ml, range: 1.5-8.2 pg/ml, p < 0.001). There was a significant correlation between interleukin 6 and the C reactive protein concentrations in patients with viral hepatitis on admission and in all patients 48 hours later, consistent with other evidence that interleukin 6 stimulates synthesis of this acute phase protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063228      PMCID: PMC1374848          DOI: 10.1136/gut.35.7.982

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Physiological inhibitors of coagulation in fulminant hepatic failure.

Authors:  P G Langley; R Williams
Journal:  Blood Coagul Fibrinolysis       Date:  1992-06       Impact factor: 1.276

2.  Behaviour of antithrombin 3 in liver disease.

Authors:  F Duckert
Journal:  Scand J Gastroenterol Suppl       Date:  1973

Review 3.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

4.  Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors.

Authors:  K Ohlsson; I Olsson
Journal:  Scand J Clin Lab Invest       Date:  1974-12       Impact factor: 1.713

5.  Determination of plasma protein S--the protein cofactor of activated protein C.

Authors:  R M Bertina; A van Wijngaarden; J Reinalda-Poot; S R Poort; V J Bom
Journal:  Thromb Haemost       Date:  1985-04-22       Impact factor: 5.249

6.  Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.

Authors:  M H Van Oers; A A Van der Heyden; L A Aarden
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

7.  Circulating interleukin 6 as a useful marker for predicting postoperative complications.

Authors:  Y Oka; A Murata; J Nishijima; T Yasuda; N Hiraoka; Y Ohmachi; K Kitagawa; T Yasuda; H Toda; N Tanaka
Journal:  Cytokine       Date:  1992-07       Impact factor: 3.861

8.  Induction of rat acute-phase proteins by interleukin 6 in vivo.

Authors:  T Geiger; T Andus; J Klapproth; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

9.  Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.

Authors:  R D Hughes; D A Lane; H Ireland; P G Langley; A E Gimson; R Williams
Journal:  Clin Sci (Lond)       Date:  1985-06       Impact factor: 6.124

10.  Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

Authors:  G Ramadori; J D Sipe; C A Dinarello; S B Mizel; H R Colten
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  7 in total

1.  Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure.

Authors:  S J Wigmore; T S Walsh; A Lee; J A Ross
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

2.  Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.

Authors:  Masahiro Shinoda; Arno W Tilles; Go Wakabayashi; Atsushi Takayanagi; Hirohisa Harada; Hideaki Obara; Kazuhiro Suganuma; François Berthiaume; Motohide Shimazu; Nobuyoshi Shimizu; Masaki Kitajima; Ronald G Tompkins; Mehmet Toner; Martin L Yarmush
Journal:  Tissue Eng       Date:  2006-05

3.  Role of monocytes and macrophages in experimental and human acute liver failure.

Authors:  Lucia A Possamai; Charalambos Gustav Antoniades; Quentin M Anstee; Alberto Quaglia; Diego Vergani; Mark Thursz; Julia Wendon
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.

Authors:  Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk
Journal:  J Hepatol       Date:  2016-12-10       Impact factor: 25.083

5.  Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.

Authors:  Asmita Pant; Anna K Kopec; Kevin S Baker; Holly Cline-Fedewa; Daniel A Lawrence; James P Luyendyk
Journal:  Am J Pathol       Date:  2018-02-16       Impact factor: 4.307

6.  Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.

Authors:  Anne Chastre; Mireille Bélanger; Elizabeth Beauchesne; Bich N Nguyen; Paul Desjardins; Roger F Butterworth
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury.

Authors:  Jürgen Borlak; Bijon Chatterji; Kishor B Londhe; Paul B Watkins
Journal:  Genome Med       Date:  2013-09-27       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.